New Zealand News Beep
  • News Beep
  • New Zealand
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
New Zealand News Beep
New Zealand News Beep
  • News Beep
  • New Zealand
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Glucagon-like Peptide-1

13 posts
HHealth
Study: Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans. Image Credit: Corona Borealis Studio / Shutterstock
Read More

Study finds GLP-1 medicines cut fat while preserving muscle function

  • March 19, 2026
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
HHealth
Patients who stop GLP-1 drugs often restart or try alternatives
Read More

Patients who stop GLP-1 drugs often restart or try alternatives

  • March 17, 2026
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
HHealth
Study: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. Image Credit: Kotcha K / Shutterstock
Read More

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

  • March 9, 2026
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
HHealth
Epigenetic editing enables safer and more effective T cell therapies
Read More

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

  • March 7, 2026
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
TTechnology
Trial: Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial. Image Credit: Alones / Shutterstock
Read More

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

  • February 25, 2026
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
MMedication
New weight-loss pill: 6 things you should know - Caledonian Record
Read More

New weight-loss pill: 6 things you should know – Caledonian Record

  • February 12, 2026
New weight-loss pill: 6 things you should know  Caledonian RecordNovo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete…
HHealth
Improving survival in people with severe psychiatric disorders
Read More

Improving survival in people with severe psychiatric disorders

  • January 26, 2026
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
HHealth
New EASD guideline combines clinical standards with lived experience
Read More

Glucose-lowering drugs may reduce risk of developing epilepsy

  • December 11, 2025
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to…
HHealth
New EASD guideline combines clinical standards with lived experience
Read More

Diabetes drugs linked to slower frailty progression in older adults

  • December 4, 2025
A new study shows that older adults with type 2 diabetes who start treatment with sodium–glucose cotransporter-2 (SGLT-2)…
HHealth
Study: Body-wide multi-omic counteraction of aging with GLP-1R agonism. Image Credit: CI Photos / Shutterstock
Read More

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

  • November 24, 2025
New multi-omic data reveal that GLP-1 signaling in the brain can drive body-wide rejuvenation, offering a potential weight-neutral…
HHealth
Healthy diet found to reduce chronic pain beyond weight loss
Read More

WHO reviews highlight limited long-term data on GLP-1 drug safety

  • October 30, 2025
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies…
HHealth
New study reveals a 25-year rise in alcohol-induced mortality
Read More

GLP-1 therapeutics may have the potential to treat alcohol and drug addiction

  • October 9, 2025
A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol…
New Zealand News Beep
www.newsbeep.com